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Abstract
This thesis is concerned with analysing vitamin A deficiency. Vitamin A is crucial for
several functions, including vision, growth, and cell differentiation. the main aim is to
develop and validate an LC-MS/MS method for the determination of vitamin A in
plasma matrix and use the new method for the determination of vitamin A levels in the
obese Emirati population. Methods: A positive ion electrospray ionisation (ESI) LCMS/MS method was used in the Multiple Reaction Monitoring (MRM) mode for
quantification. It involved i) LC-MS/MS, ii) a guard column together with C18
Ascentis Express F5 column iii) Internal standard, 25-Hydroxyvitamin D3 (6, 19, 19d3), and iv) identification via ESI and monitoring of three fragmentation of the parent
ion. To demonstrate the practical value of this method, blood samples were collected
from 452 Emirati participants (277 obese; 175 healthy). The method was validated
according to FDA-US guidelines. The method has been applied on a sample of 277
Emirati obese patients, including 277 baselines, 277 follow-ups, and 175 health
samples. The characteristics of the sample included: mixed-gender with 73 males in
the age group of (18–82 years) and 204 females in the age group of (18–65 years). The
results show that the concentrations of vitamin A for both females and males increased
after supplementation (372 ng/mL to 440 ng/mL for female sample, and 438 ng/mL to
540 ng/mL for male sample). This has led to a sufficient level of vitamin A in
participants. The new method allowed chromatographic separation and quantification
of vitamin A. The new assay could detect 0.48 ng/mL of vitamin A in serum with the
calibration curve ranging from 7.8 to 1000 ng/ml. The method validation parameters,
including intra and inter-day precision, intra and inter-day accuracy, recovery,
linearity, specificity, and stability, were within range. For example, the recovery
percentage found were 99%, 96%, and 94% for QCH, QCM, and QCL respectively,
while the percentage of change in the stability of vitamin A ranges between 0 and 3%.
The applied LC-MS/MS method was intended to accurately detect Vitamin A in
human plasma, and has proven to be specific, reliable, and robust. The method can
detect low levels of vitamin A. This analytical method does not require timeconsuming derivatisation and complex extraction techniques and could prove very
useful in clinical studies.
Keywords: Vitamin A, LC-MS/MS, ion dispersion, chromatographic separation.
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)Title and Abstract (in Arabic

التحديد الطيفي الشامل للريتانول لسكان دولة اإلمارات
الملخص

مقدمة :هذه الرسالة معنية بتحليل نقص فيتامين أ الذي يعد من أهم العناصر الغذائية للعديد من
الوظائف  ،بما في ذلك الرؤية والنمو وتمايز الخاليا .األهداف :الهدف الرئيسي هو تطوير والتحقق
من صحة طريقة  LC-MS / MSلتحديد فيتامين أ في مصفوفة البالزما واستخدام الطريقة
الجديدة لتحديد مستويات فيتامين أ في السكان اإلماراتيين البدينين .الطرق :تم استخدام طريقة
 - LC-MS / MSاللوني السائل مع مطياف الكتلة الترادفية  -للتأين بالرش الكهربائي األيوني
الموجب في وضع مراقبة التفاعالت المتعددة ( )MRMللتقدير الكمي .تضمنت LC-MS / )1
 )2 ،MSعمود حماية مع عمود  )C18 Ascentis Express F5 iiiالمعيار الداخلي -25 ،
 ، )-d319 ، 19 ،Hydroxyvitamin D3 (6و  )4تحديد عبر  ESIومراقبة ثالثة تجزئة
لأليون األصل .إلثبات القيمة العملية لهذه الطريقة  ،تم جمع عينات دم من  452مشار ًكا إماراتيًا
( 277سمينًا  175 ،صحيًا) .تم التحقق من صحة الطريقة وفقًا إلرشادات إدارة الغذاء والدواء
األمريكية .النتائج :تم تطبيق الطريقة على عينة من  277إماراتي مريض يعانون من السمنة
المفرطة  ،بما في ذلك  277عينة أساسية  ،و  277تم متابعتهم  ،و  175عينة صحيحة .اشتملت
خصائص العينة على :عدد من  73من الذكور في الفئة العمرية ( 82-18سنة) و  204إناث في
الفئة العمرية ( 65-18سنة) .أظهرت النتائج أن تركيزات فيتامين (أ) لكل من اإلناث والذكور
زادت بعد المكمالت ( 372نانوغرام  /مل إلى  440نانوغرام  /مل لعينة اإلناث  ،و  438نانوغرام
 /مل إلى  540نانوغرام  /مل لعينة الذكور) .وقد أدى ذلك إلى مستوى كافٍ من فيتامين أ في
المشاركين .مساهمات كبيرة :سمحت الطريقة الجديدة بالفصل الكروماتوغرافي وتقدير فيتامين أ.
يمكن للمقايسة الجديدة اكتشاف  0.48نانوغرام  /مل من فيتامين أ في مصل الدم مع منحنى
المعايرة الذي يتراوح من  7.8إلى  1000نانوغرام  /مل .كانت معلمات التحقق من صحة الطريقة
 ،بما في ذلك الدقة داخل وبين اليوم  ،والدقة داخل وبين اليوم  ،واالسترداد  ،والخطية ،
والخصوصية  ،واالستقرار  ،ضمن النطاق .على سبيل المثال  ،كانت نسبة االسترداد التي تم
العثور عليها  ٪99و  ٪96و  ٪94لـ  QCHو  QCMو  QCLعلى التوالي  ،بينما تتراوح
النسبة المئوية للتغير في ثبات فيتامين  Aبين  0و  .٪3تم ملء الفجوة :طريقة LC-MS / MS
المطبقة كانت تهدف إلى الكشف الدقيق عن فيتامين أ في بالزما اإلنسان  ،وقد ثبت أنها محددة
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وموثوقة وقوية .يمكن لهذه الطريقة الكشف عن المستويات المنخفضة من فيتامين أ .ال تتطلب هذه
الطريقة التحليلية اشتقاق تقنيات استخالص معقدة وتستغرق وقتًا طويالً ويمكن أن تكون مفيدة جد ًا
في الدراسات السريرية.
مفاهيم البحث الرئيسية :فيتامين أ ،LC-MS/MS ،التأين بالترذيذ األيوني ،الفصل
الكروماتوغرافي.
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Chapter 1: Introduction
1.1 Background
Many organisms need limited amounts of organic compounds in their body; one of
these compounds is vitamins. Vitamins play an essential vital role in the body, like
activating an enzyme to catalyse a thousand chemical reactions; so, they are considered
as co-factors in enzyme activity [1]. They play a crucial role as antioxidants and prohormone agents. Moreover, they are necessary for various physiological, biochemical,
and catalytic functions. Ultimately, they are involved in the metabolism of food
substances [2]. Vitamins are required in small quantities and, as such, are referred to
as micronutrients. The body does not synthesise most vitamins except for vitamin D,
which can be obtained by skin exposure to sunlight [3]. Therefore, diet acts as a
significant supply source [3]. Each vitamin has its own set of functions; therefore, the
body requires different amounts of each vitamin [4]. Vitamin deficiency is associated
with several conditions such as pernicious anaemia, scurvy, pellagra, ariboflavinosis,
skin conditions, and many others. It is caused by a poor diet, malabsorption, or
underlying medical disease [4, 5]. Vitamins’ solubility is categorized into two clusters,
the first group is water-soluble vitamins while the second group is fat-soluble vitamins.
Vitamins B and C are under the group of water soluble vitamins, while vitamins A, D,
E, and K are under the group of fat-soluble vitamins [1].
Vitamin A has an organic structure of an 11-carbon side chain and a 6-membered ring.
Vitamin A is not a single molecule, it is a name given to a group that contains some
related compounds, and they include Retinol (primary molecule, vitamin A alcohol),
Retinal and Retinoic acid [6, 7]. Retinol and other compounds, including retinal,
retinoic acid, and retinyl esters, have a similar biological activity to vitamin A;
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therefore, the term vitamin A is utilised for these compounds as presented in Figure
number 1 [7]. Retinoids are a group of chemical compounds that are metabolites of
vitamin A and contain four isoprenoid units. These isoprenoid units linked together in
a head-to-tail manner to form Vitamin A metabolites as shown in figure number 1
[7, 8].
Retinol can be converted by oxidation to retinal; also, Retinal can be changed to
retinol; therefore, these two compounds are interconvertible. Retinal is main source of
Retinoic acid which is derived from by oxidation, which is also at the same time a
critical signalling molecule; however, retinoic acid cannot be converted to retinal by
reduction [9]. Plants contain vitamin A in a pro-vitamin form that is known as βcarotene. β-carotene is derived from carrots because carrots have a rich concentration
of vitamin A. β-carotene is an antioxidant which can be converted in the body to
vitamin A by an enzyme called β-carotenoid-15,15′-dioxygenase. For instance, this
enzyme cleaves β-carotene in a specific region (central region) into two molecules of
retinal; then, these two molecules are converted into retinol during the reduction
process catalysed by retinal reductase enzyme as appears in the Figure 1 [7, 10, 11].
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Figure 1: The metabolic relationships between a group of vitamin A compounds
including retinal, retinol, β-carotene, retinoic acid, and retinyl ester
Moreover, this figure illustrates the molecular structure of α-carotene, Isoprenoid unit,
11-cis-retinal, and 9-cis-retinoic acid. β-carotenoid-15,15′-dioxygenase enzyme
cleaves β-carotene into two molecules of retinal; then, Retinal converted to retinol by
retinal reductase enzyme, and there will be interconversion reaction between Retinal
and Retinol. Retinoic acid considered the most active biological metabolite of vitamin
A produced irreversibly from retinal by an oxidation process [7].
Retinol is considered the common active metabolite biologically present in the tissue
of mammals. Retinol solution has a faint yellow colour, and it can be adversely
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affected by heat, oxygen, ultraviolet light, and acids [12]. Vitamin A is an essential
component needed for healthy vision. There is no need for a prescription to take this
vitamin. In the United States, some foods like cereals have a large amount of this
vitamin. Undoubtedly, it is proposed that a large amount of vitamin A intake could
lead to fracture and osteoporosis in some countries like Scandinavia and the United
States, where vitamin A is often consumed highly in food and supplements [7].
The human body must have vitamin A in an adequate amount for many functions,
including physical development and growth, vision, regular gene expression, immune
function, reproduction, and erythropoiesis [13]. The human body requires a specific
amount of vitamins depending on age and gender, as well as other factors such as
health status and pregnancy. The Food and Nutrition Board of the Institute of
Medicine’s Recommended Dietary Allowance (RDA) ranges from 0.3mg- 0.9 mg per
day. So the best way to ensure your body gets its daily requirement of essential
vitamins is to eat a balanced meal containing a wide variety of fruits, vegetables, whole
grains, and dairy products [14].
Various analytical procedures could be utilised in the pre-treatment and determination
of vitamins. For pre-treatment, ultrasonic-assisted extraction, liquid-liquid extraction,
solid-phase extraction, and dispersive liquid-liquid microextraction are the most
common methods. Determination analysis includes chromatography techniques,
electrophoretic methods, microbiological assays, immunoassays, biosensors, and
several other methods [15-20].
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1.2 Aims and objectives of this study
1.2.1 Aim
The aim of this study was to develop and validate an LC-MS/MS method for
determination of vitamin A in plasma matrix and use the new method for determination
of vitamin A levels in obese Emirati population.
1.2.2 Objectives
1. Develop a sensitive robust, and easy LC-MS/MS-based assay for measuring
vitamin A in human plasma.
2. Use the above method to measure plasma vitamin A in healthy and diseased
Emirati population.
1.3 Hypothesis
1. Obese Emirati patients have low levels of vitamin A compared to healthy.
1.4 The importance of vitamin A for vision
In the early 1500 BC, vitamin A was significantly important to ancient Egyptians for
vision health. As reported by papyrus Ebers (ancient herbal knowledge of medicine),
patients who have night blindness disease or nyctalopia patients who were face
difficulty in seeing either during the night or in dim light. Those patients were treated
by using the specific medication as a topical application in their eye. It is called liver
juice or previously cooked ox liver extract [9, 21, 20]. The drops of this medicine
contain a large amount of vitamin A (Retinol). They come to the retina through firstly
getting in the lachrymal duct and then absorbed through blood circulation [9, 22].
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In Figure 1, it is shown that 11-cis-retinal is a Vitamin A derivative that plays a vital
role in the rod cells located in the retina of the eye. Rod cells are the photoreceptor
cells that have a specific type of vision, which is called scotopic vision; so, it is more
for dim light or dark light. Rod cells consist of a specific type of visual pigment, and
this pigment is called Rhodopsin. Rhodopsin is made up of two things. The first thing
is that retinal, which is 11-cis-retinal, and the second thing is that opsin protein, which
is sensitive to the light [9, 10].
When the light rays absorbed by rod cells, they hit the Rhodopsin and change the
structure of 11-cis-retinal into a different form, which is called all-trans-retinal;
therefore, the attraction of this molecule toward opsin protein is loosed which lead to
initiate phototransduction process. In the phototransduction process, the light is
converted into an electrical signal which is transmitted toward the brain resulting in
the vision [9, 23-25]. Vitamin A deficiency precedes to night blindness symptoms. For
example, When the amount of 11-cis-retinal is less, the body cannot make Rhodopsin
(light-sensitive protein), and a subsequently small amount of light cannot stimulate an
adequate response at night [7, 26].
1.5 Dietary sources of vitamin A
Vitamin A can be found in the diet either as pro-vitamin A carotenoids or as
preformed vitamin A. Retinyl ester is a long-chained fatty acids ester of retinol and
considered as major preformed vitamin A. It can be ingested in foods such as liver,
milk, butter, eggs, and fortified cereals. Moreover, Vitamin A can be obtained as provitamin A carotenoids, including β-carotene, α-carotene, and β-cryptoxanthin from
vegetables such as pumpkins, collards, carrots, squash, and spinach. In the United
States, the percentage of β-carotene ingestion exceeds more than 75% compared to the
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other pro-vitamin A carotenoids [27, 28]. “The Recommended Dietary Allowance
(RDA) for adults for vitamin A is set at 900 ug RAE/day for men and 700 ug RAE/day
for women. One ug retinol activity equivalent (ug RAE) is equal to 1 ug all-transretinol, 12 ug β-carotene, and 24 ug α-carotene or β-cryptoxanthin” [14]. In the United
States, the mean of vitamin A intake is approximately 600 ug RAE/day and preformed
vitamin A intake formed 70 -75% of that concertation [27].
1.6 Absorption and transport of vitamin A
The biologically inactive retinyl esters are broken down via hydrolysis with pancreatic
and intestinal enzymatic catalysation [29, 30]. The resultant unbound and insoluble
retinol is then absorbed by enterocytes and converted from its unbound state to binding
with one of the cellular retinol-binding proteins (CRBP). From the six distinct binding
proteins, Intestinal Retinol binds preferentially to CRBP type II [31]. In contract to
preformed vitamin A, absorption of pro-vitamin A carotenoids occurs either directly
by intestinal muscoal cells or by conversion through oxidation to Retinal, followed by
reduction to retinol [32]. Retinol esterification occurs with retinol obtained from
retinyl esters and pro-vitamin A, through incorporation with long-chain fatty acids.
The retinyl esters alongside the unmodified carotenoids are packaged with the rest of
dietary lipids into chylomicrons, which are carried by the lymphatic system [33].
There is also a notion that some retinol which has not undertaken esterification is
uptaken directly by the hepatic portal system.
Dietary fat plays a fundamental role in the absorption of vitamin A. This occurs
through several processes by stimulation of chylomicron production and improving
the solubility of retinol and carotenoids in the intestinal mucosa while also initially
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aiding in the activation of enzymes acting to performs hydrolysis of dietary retinyl
esters [27].
The formation of chylomicron remnants in the bloodstream where retinyl esters are
contained occurs as a result of hydrolysis with a function of the enzyme lipoprotein
lipase, accompanied by the addition of apolipoprotein. This facilitates hepatic retinol
uptake through endocytosis, followed by hydrolysis [31]. It has been proposed that the
enzyme lipoprotein lipase (LpL) performs this function in peripheral tissues,
facilitating hepatic retinol uptake through endocytosis followed by hydrolysis [34].
Retinol surplus to the body's need is re-esterified and transferred to the hepatic stellate
cells for storage.
With 70% storage, the liver is the main tissue site of vitamin A storage in the body.
This is in addition to the extrahepatic uptake of chylomicron and remnants, where
small portions of retinyl esters and carotenoids are transferred for usage and storage
[31] (Figure 2). Once retinol has formed in liver stellate cells from its storage structure
of retinyl esters, it binds to a specific transport protein known as Retinol binding
protein (RBP) at the hepatocytes. The exact mechanism of which has been the subject
of much research. The resultant compound of retinol-RBP then binds to transthyretin
in the circulation [35]. This process prevents the renal clearance of retinoids [36].
Immediately following consumption of a meal, retinoid is found in a significant
proportion within the circulation in the form of chylomicron retinyl esters while
retinol-RBP complex constitutes for the vast majority present in fasting conditions
[37].
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Figure 2: The absorption and transport of vitamin A highlighting the uptake pathway
from dietary sources (Dietary uptake and transport of vitamin A) [7]
1.7 Metabolism of vitamin A
Retinoids within the circulation are taken up by peripheral tissue in the form of an alltrans-retinol complex with RBPs. A small proportion of dietary retinoid accounting
for 25-33%, however, is taken by other non-hepatic tissue in chylomicrons [31].
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Research studies in-vivo have found that chylomicrons deliver vitamins to bonebuilding cells known as osteoblasts making the bone an essential organ in the uptake
of chylomicron remnants [38].
Peripheral tissue uptake of chylomicron retinyl esters occur following the hydrolysis
of chylomicron retinyl esters by the action of lipoprotein lipase. The uptake RetinolRBP complex, on the other hand, occurs predominantly via a specific cell surface
receptor known as STRA6, which is a multi-transmembrane retinoic acid-responsive
gene. Furthermore, the active form of all-trans-retinoic acid (ATRA) is found albuminbound in small amounts in serum, contributing to tissue uptake of ATRA [39].
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Immediately post the uptake of retinol by cellular tissues, it is transformed into the alltrans-retinal by oxidation with the action of dehydrogenases within the cytosol. It then
binds with CRBP. Following this, the biologically active complex ATRA is formed as
all-trans-retinal is oxidised in a process regulated by retinal dehydrogenase. Cellular
retinoic acid-binding protein (CRABP) selectively binds ATRA, the most active
retinoid metabolite. Retinoids exert their effects through the binding to nuclear
receptors, mainly retinoic acid receptors (RAR) and retinoid X receptors (RXR),
alongside the action of response elements and multiple core regulators [26] (Figure 3).
Both RAR and RXR families exhibit three receptor isotypes (α, β, γ) with at least two
different isoforms present for each isotype [40].
Retinoid receptors bind to retinoids in the form of dimers leading to the activation of
retinoic acid response elements (RAREs) in the promoter parts of genes at the target
site. RARs only work in the form of heterodimers with RXRs (RAR/RXR), with RXRs
able to also function as only homodimers (RXR/RXR). RXRs also possess the ability
to form heterodimers with various nuclear receptors like vitamin D, demonstrating the
involvement of retinoids in various cellular pathways. Research has shown that RARs
activation is mediated by ATRA and the isomer9-cis retinoic acid (9-cis RA) in vitro,
while RXRs bind to 9-cis RA, resulting in its activation. The majority of cellular retinol
signaling is believed to occur with the binding of ATRA to RAR in RAR/RXR
heterodimers [41].
Active RARs act as ligand transcription factors, binding RAREs in the promoters of
target genes [40, 41]. RAREs are made up of hexameric motifs organised as 1, 2, or 5
palindrome pairs DRs or inverted repeats. RA can be shuttled to the nucleus by cellular
CRABP-II, which facilitates the movement of ATRA to RARs. Retinoic acid receptors

13
serve an essential role in the regulation of this pathway through the recruitment of coactivators and corepressor proteins controlling the transcription of target genes
depending on the presence of the retinoic acid ligand. In the absence of the ligand, the
RAR/RXR complex represses the transcription process by recruiting corepressors,
while the binding of ATRA to the RAR/RXR dimer leads to the recruitment of coactivators. Examples of co-activators include steroid receptor co-activator (SRC)/p160
family and p300/CREB-binding protein (CBP) while corepressors include nuclear
receptor corepressor (NCoR), silencing mediator of RAR and thyroid hormone
receptor (SMRT), mSin3A, and histone deacetylases (HDACs) [40, 42-44] (Figure 3).
It has been found that RAR-mediated gene repression is essential in skeletal progenitor
differentiation signalling pathways to regulate the emergence of the chondroblast
phenotype [45, 46].
Peroxisome

proliferator-activated

receptors

(PPARs)

are

ligand-activated

transcription factors of the nuclear hormone receptor with three subtypes PPARα,
PPARγ, and PPARβ/δ. PPARs dominate the capability to produce heterodimers with
RXR, as well as RARs and RXRs. Following heterodimerisation with RXR, PPARs
function as a sequence-specific target factor in the promoter region of target genes [47,
48] (Figure 3).
As well as functioning as a ligand RARs, it has been found that ATRA can also bind
to PPARβ/δ [43]. The fatty acid-binding protein 5 (FABP5) mediates this pathway by
shuttling ATRA to the nucleus, enabling PPARβ/δ activation, allowing the subsequent
binding to PPAR response elements (PPREs) to take place [49, 50]. The notion that
dual transcriptional activities from alternate activation of two different nuclear
receptors (CRABPII/RAR or FABP5/ PPARβ/δ) underlie opposing effects of RA on
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cell growth has been shown in keratinocyte proliferation and carcinomas, with a
paucity of evidence in bone cells.
Retinoid-related orphan receptors, mainly RORα and RORβ, represent another group
of transcription factors that have been found to bind to retinoids [51]. While RARs and
PPARs bind RXR is a heterodimer binding mode, RORs undertakes monomeric DNA
binding to specific ROR response elements (ROREs) [52]. Recent studies have shown
that RORβ has resulted in the failure of mineralisation and osteoclast differentiation
[53].
The impact of retinoids at a genomic level can, therefore, be demonstrated through
the regulation of multiple physiological processes through the retinoic acid receptordependent transcription pathway encompassing the ligation of ATRA to different
types of nuclear receptors and the binding to the relevant response elements. In
addition to this classical genomic-based mechanism, retinoids can also exert nongenomic effects. These nongenomic effects could either be facilitated by RARs or
without RARs involvement.
Non-genomic effects mediated by RARs include RARs inhibitory effect as an RNAbinding protein within the cytoplasm of neuronal cells [54, 55]. The regulation of
ERK1/2 kinase phosphorylation is an example where non-genomic effects are
displayed independent of RARs. Phosphorylated ERK1/2 leads to phosphorylating
various microtubule-based proteins, and it also translocates to the nucleus resulting in
the activation of various transcription factors such as cAMP response element-binding
(CREB) protein which is important for axonal growth [56] (Figure 3). This action is
not only exerted by ATRA but also by retinol [57].
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Adipose tissue is a major storage area for retinol, where it has shown a potent inhibitor
activity of adipocyte differentiation, as well as inhibiting of PPAR activity, and
improves sensitivity to insulin [55]. This finding highlights that retinal could be a
further compound derived from vitamin A, which is essential in facilitating a
biological function. Unlike Retinol, ATRA acts as a paracrine factor due to its ability
to pass through hydrophobic membranes, which is attributed to its partial water
solubility. These acts display retinoic acid immersion and engagement acting as a
morphogen in early embryonic development.
1.8 Vitamin A deficiency
Safe and optimal vitamin A supplementation has shown a considerable positive
influence on improving several physiological functions, including the immune system.
With the exception of developing countries where there have been high levels of
vitamin A deficiency, this simple and cost-effective approach has had a detrimental
impact on reducing mortality worldwide [58]. The application of therapeutically used
retinoids extended to reducing acne outbreaks. It has also been integrated into the
management of different cancers, including acute promyelocytic leukemia, squamous
cell carcinoma of the head and neck as well as ovarian cell carcinoma [59].
There are several factors affecting retinol levels within the body, with increased levels
associated with an increase in age as well as high body mass index in children [60, 61].
This could be attributed to increased intestinal uptake and reduced clearance. It has
also been found that the level of retinyl esters in the serum is higher in females than
males and in those who self-medicate with vitamin supplements [63-66]. Normal
values range from 1-3 µmol/L, with suboptimal vitamin A status at <1.05 µmol/L and
a deficiency diagnosis with <0.7 µmol/L [60, 61].
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Measuring vitamin A levels in the human body has been the subject of much research.
Serum retinol and retinyl ester concentrations have been used as commons methods in
order to assess the status of vitamin A. However, with the controlled release of vitamin
A from its liver storage reserves only when needed, this method is only beneficial at
extreme amounts of vitamin A, when these are either dangerously low or high [62].
While serum retinyl esters have been found to be beneficial for chronic cases, other
sensitive biochemical methods to marginal changes in vitamin A storage are necessary
in order to ascertain clinically significant levels with relevance to toxicity [63]. These
encompass dose-response tests and isotope dilution assays [62].
Serum retinyl ester concentrations of 0.2 µmol/L, or more than 10% of total serum
vitamin A, including both retinol and retinyl esters, provide an indication of
abnormally high and potentially toxic concentrations. The scale of an increased
vitamin A level has been highlighted by the Third National Health and Nutrition
Examination Survey, where cases of more than 10% of total vitamin A has been
significantly high, showing an increased incidence [64].
While a high intake of preformed vitamin A or retinoid derivatives can lead to
hypervitaminosis A, pro-vitamin A carotenoids such as B-carotene do not cause
hypervitaminosis A, even when consumed in large quantities. This is due to the
negative feedback regulation, which limits the conversion of B-carotene to Retinol in
order to align with the actual need of the body [65]. Excessive dietary carotenes can
cause carotenemia, yellowing of the skin, which is a reversible medical condition on
stopping the ingestion of beta-carotene [66].
Evidence suggests that hypervitaminosis A existed a very long time ago with a partial
Homo erectus skeleton displaying pathological bony alternations in the outer cortex of
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the tibial shaft, corresponding with chronic hypervitaminosis A [67]. It has been
suggested that this was a result of the change in the Homo erectus diet at the time to
include animal liver, which is a rich source of vitamin A, leading acutely to vertigo,
vomiting, diarrhea, headache, seizures, patchy hair loss, and even mortality in some
cases. The earliest known description of this illness in the West was documented by
Gerrit de Veer, an early Dutch explorer on a 1596 voyage with William Barentsz to
find the Northwest Passage [68]. De Veer's diary describes a sickness that occurred
after his crew ate polar bear liver—which contains a high concentration of vitamin A.
Similarly, in the 1850s, Arctic explorer Elisha Kent Kane initially thought that the
widespread caution about polar bear liver was a "vulgar prejudice," but he
subsequently changed his mind: "The cub's liver was my supper last night, and today
I have the symptoms of poison in full measure-vertigo, diarrhea, and their
concomitants" [69]. In the Far Eastern Party of the 1911-1914 Australasian Antarctic
Expedition, acute hypervitaminosis A may have caused sickness and death among
many polar explorers who ate the livers of Greenland husky sled dogs [70].
Hypervitaminosis A is a rare condition with higher incidence found in children
generally attributable to therapeutic retinoids or candy-like chewable vitamin
supplements [71]. The rise in misconceptions related to the safe use of vitamins
without realisation of the need to ensure consumption is within the recommended daily
limit makes this disease of importance in terms of severity and the potential increase
in incidence. The highest risk is believed to be related to emulsified, water-soluble,
and solid preparations, such as tablets [71].
Hypervitaminosis can lead to skeletal lesions as evident in studies showing a
characteristic thinning of the cortex and a decrease in the diameter of the long bones
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(Figure 4). Findings have also shown a strong association between excessive vitamin
A intake and an increased risk of fracture as exposure to toxic doses of retinoids
resulted in spontaneous fractures in rats [72]. A further indication of the skeletal
changes associated with hypervitaminosis A reduced endosteal/marrow blood flow
accompanied by a higher degree of mineralisation has been shown in rats with
hypervitaminosis A. Furthermore, the bone marrow of rats ingested with retinol
displayed a high level of osteogenic genes [73].
While most studies have been undertaken on retinoid-treated rats with exposure to
excessive amounts that do not lead to toxic levels in humans, mature rats that received
considerably lower doses of vitamin A still displayed long thin bones and decreased
biomechanical strength [74]. This supports the notion that humans with subclinical
elevations in vitamin A are at an increased risk of fractures and osteoporosis.
The skeletal effects studied in humans with an abundant consumption of retinoids
found there to be periosteal bone formation characterised by hyperostosis in
metatarsals, metacarpals, and the long bones in the body. Other skeletal effects were
found comprised of premature epiphyseal closure, skeletal and joint pain, and
increased cortical bone resorption [75, 76].
In one microradiography study of a human rib, large consumptions of vitamin A
displayed six times more cortical bone resorption as well as suboptimal bone formation
(Figure 4) [77]. Even after the restoration of normal vitamin A consumption, humans
who previously consumed too much vitamin A had evidence of new subperiosteal
bone, particularly in the tibial and fibular shafts [78].
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It is worth noting that hypercalcemia has been linked with hypervitaminosis A in
numerous case reports, likely because retinoids directly promote bone resorption
[79, 80]. This hypercalcemia can be addressed with glucocorticoids, which have been
shown in vitro to reduce hypercalcaemia by activating the monomeric glucocorticoid
receptor and thus opposing bone resorption of ATRA [79-82].
Figure 4 shows that increased vitamin A intake leads to decreased cortical bone mass
by increasing the number of osteoclasts on the periosteal surfaces as shown in part A.
Part B highlight the controversy of the role of Vitamin A on trabecular bone some
studies showing effects on bone mass. In contrast, others provide evidence otherwise.
Part C shows the role Vitamin A plays in inhibiting adipocyte differentiation, as shown
in vitro studies.
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Table 1 shows examples of HPLC-MS/MS methods for the detection of vitamin A.
Pre-treatment and determination methods of vitamins have increasingly been a subject
of research interest over the years. Analytical techniques include a pre-treatment
process in order to minimise interference of other components and as such enhance the
analytical performance. Pre-treatment approaches are varied and include liquid-liquid
extraction (LLE), ultrasonic assisted extraction (UAE) and super critical fluid
extraction (SFE) alongside other processes (Table 2). Each of these techniques have
specific advantages and disadvantages which have been discussed in many studies
(Table 3). Depending on the type of sample, UAE, SFE and reflux are the most widely
used for solid preparations while LLE, solid-phase extraction (SPE) and Dispersive
Liquid–Liquid Microextraction (DLLME) are the techniques of choice in the liquid
phase formulations. SFE offers a good efficiency of extraction despite its expensive
instruments when compared with UAE. In discussing column passing, processes like
SPE can be complex. Nonetheless, SPE provides an ability to prepare several samples
at the same time, significantly reducing the total time of the process. In addition, SPE
could be coupled with LC to provide analysis within an online platform [20, 83, 84].
As well as the various types of pre-treatment methods, there are many analytical
approaches and these include chromatography techniques, electrophoretic methods as
well as microbiological and immune assays. The most widely used techniques in the
determination of vitamins are those that are based on High-Performance Liquid
Chromatography-Tandem Mass Spectrometry (HPLC–MS) or (HPLC-MS/MS)
(Table 1). Advances within this technique have led to the development of ultra-highperformance liquid chromatography (UHPLC) which utilises sub-2-μm particle
columns with a subsequent enhancement of the chromatographic performance,
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particularly within resolution, sensitivity and speed. Combining UHPLC with MS
detectors has also shown several advantages [17, 18, 85].
In discussing advantages, Liquid Chromatography (LC) offers a wide variety of
qualitative and quantitative analytical benefits in various matrices, including foods and
biological preparations, particularly when used with MS. The use of other techniques
such as ultraviolet (UV) and Fluorescence Detectors (FLD), has been limited by
overlapping peaks with complex samples [17, 18, 85].
The key favourable characteristics of LC-MS/MS is the increased specificity and
sensitivity in comparison to other methods. This is because it can easily distinguish
between various metabolites through chromatographic separation and mass transition
variation. LC-MS/MS methods can separate samples with different polarities and mass
to charge (m/z) ratios. In addition, this method posses very Low Limits of Quantitation
(LOQ), subsequently providing a higher sensitivity. Therefore, LC-MS/MS provides
accuracy and precision [15].
HPLC-MS/MS can also act as a confirmatory technique in the identification of
vitamins leading to easily identifying the sample’s molecular structure. Utilising
MS/MS provides flexibility as complete HPLC separation of the sample constituents
would not be essential for selective detection. Key drawbacks for HPLC-MS/MS
includes high costs and matrix effects. In essence, matrix effects are when high
contents of organic components, from extracts of various matrices, affect the
evaporation and ionisation of the analytes [15].
Measuring vitamins in different samples was carried out successfully in many studies
utilizing methods based on HPLC-MS/MS. With reference to vitamin A, Midttun and
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Ueland [17] quantified three types of vitamins in a small amount of human plasma at
the same time. The LOD for trans-retinols were 0.10 μM for 25-OH D2 while 25-OH
D3 showed 3.3 nM. Therefore, HPLC-MS/MS can meet the requirements for
measuring vitamins and can be applied to preparations of biological nature. The main
key advantages involve simplicity with minimal preparation, pace (analysis time does
not take longer than 5 min) and high sensitivity [20, 83, 84].

Table 1: Examples of HPLC-MS/MS methods for the detection of vitamin A
Instrument Analysis Methods

Limit of Quantification
(LOQ)

High Performance Liquid
0.1 μg/100 mL for all transChromatography–Ion Trap Mass retinol and α-tocopherol and
Spectrometry (HPLC–Msn)
1 μg/100 mL for β-carotene

Limit of Detection
(LOD)

Mobile Phase

Column

Analysis
Time
(min)

Ref.

no report

A: water; B: methanol. Gradient

Polaris C18 column (2.1 × 150 mm, 5 μm)

26 min

[83]

A: Ammonium formate in MeOH; B: H2O.
Gradient

Ascentis Express C18 column (4.6 × 50 mm,
2.7 μm)

6 min

[17]

ACE-100 C18 (2.1 × 100 mm, 3 μm)

30 min

[18]

30 min

[85]

45 min

[86]

7 min

[87]

Fat-soluble vitamins and their ISs were
retained in the chromatography column

18 min

[88]

BEH Phenyl column (2.1 mm × 100 mm,
1.7 μm).

4.5 min

[89]

10 min

[90]

12 min

[91]

Liquid
Chromatography/Tandem Mass
Spectrometry

no report

0.1 μM for all-trans
retinol, 3.3 nM for
25-OH VD2 and
25-OH VD3

HPLC-MS/MS

0.2–520 ng/mL

0.07–170 ng/mL

A: 10 mM ammonium acetate solution (pH
4.5); B: MeOH with 0.1% acetic acid; C:
MeOH with 0.3% acetic acid. Gradient

LC-DAD-MS/MS

2.7–46.8 μg/L

0.9–15.6 μg/L

A: Methanol; B: isopropanol/hexane
(50:50, v/v). Gradient

LC-MS/MS

n.d.

n.d.

A: 20 mM ammonium formate (pH 4.0); B:
methanol. Gradient

SPLC-MS/MS

n.d.

n.d.

(retinol-d6 and α-tocopherol-d6) in 70%
methanol in acetonitrile

LC-MS method

1.4 ng

1.6 ng

LC–MS/MS

0.00972 mg/L

n.d.

LC–MS/MS

0.1 μmol/L

0.1 μmol/L

Mobile phases A and B for fat-soluble vitamin
method were 9:1 (v/v) ACN/water and 100%
MeOH, both containing 5 mM ammonium
formate
Mobile phase A contained water with 0.1%
formic acid, and phase B consisted of
methanol.
Mobile phases A (MpA) 0.1% formic acid and
2% methanol in milli-Q water
Mobile phases B (MpB) 0.1% Formic acid in
methanol

LC-MS/MS

n.d.

n.d.

Mobile phase additives, formic acid and
ammonium formate, LC-MS grade water and
methanol, Acetone.

a Supelcosil C18 (4.6 mm × 50 mm, 5 μm)
and an Alltima C18 (4.6 mm × 250 mm, 5
μm) for fat-soluble vitamins, ProntoSIL
C30 column (4.6 × 250 mm, 3 μm) for
carotenoids
Cadenza CD-C18 stationary phase (4.6 × 250
mm, 3 μm particles)
Cyclone P (5 × 50 mm) TurboFlow™
column (Thermo-Scientific, Waltham, MA).
Shimazu, Kyoto, Japan) equipped with a
Brownlee Spheri-5 RP-18 (4.6 × 250 mm)
column.

column (Pursuit Pentafluorophenyl (PFP)
(150 mm × 2 mm × 3 μm, Cat no.
A3051150 × 020)
A Restek Raptor Biphenyl (2.7 µm dp,
2.1 mm ID, 100 mm length; Bellefonte, PA)
analytical column and a Shim-pack MAYIC4(HP) (10 mm × 4.6 mm, 50 µm dp) high
pressure restricted access media trap column
from Shimadzu were used
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Table 2: Pre-treatment methods, sample matrices and targets of the recent articles
Pretreatments
liquid-liquid
extraction
(LLE)

Determination
Methods
liquid
chromatographyultraviolet
detection (LCUV)

Sample Matrix

Analytes

Human serum

Vitamins A (retinol,
retinyl esters), E (α- and
γ-tocopherol) and D (25OH vitamin D)

LLE

LC-UV

Human serum

UAE

LC-UV

Vitamin tablets

LLE

LC-UV

UAE

LC-UV

LLE

LC-MS

Bovine milk

LLE

LC-MS

Human plasma

UAE

LC-DAD-MS

Green leafy vegetables

UAE

LC-MS

UAE

MEKC

UAE

MEKC

LLE

MEKC

Dilute and
shoot

Spectrofluorimetry

Centrifugation
SPE

HPLC, ELISA
LC-UV

Pharmaceutical
formulations
Food samples, human
plasma and human
adipose tissue

Nutritional
formulations
Commercial
multivitamin
pharmaceutical
formulation
Multivitamin
formulation
Multivitamin tablets
and vitamin E soft
capsules
Multivitamin drugs,
food additives and
energy drinks
Serum
Plasma

All-trans-retinol, retinyl
acetate, a-tocopherol, atocopheryl acetate
10 vitamins (7 watersoluble and 3 fatsoluble)
Fat-soluble vitamins
Retinol, tocopherols,
coenzyme Q10 and
carotenoids
Vitamins A, E and bcarotene
Vitamins A, D and E
Fat and water-soluble
vitamins
Fat- and water-soluble
vitamins

Ref.

[92]

[93]
[94]
[95]
[96]
[83]
[97]
[18]
[85]
[86]

Water- and fat-soluble
vitamins
Water- and fat-soluble
vitamins

[98]
[19]

Fat-soluble vitamins
Fat- and water-soluble
vitamins
Vitamins A, C and D
Retinol and α-tocopherol

[99]
[100]
[19]
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Table 3: Determination methods advantages and disadvantages
Determination Advantages
Methods
•
LC-UV
[94]

•

•
LC-MS
[97]

•

•
•

MEKC
[98]

•
•
•
•

Nondestructive, very
reliable, and easy to use.
Near-universal detection of
organics at low UV
wavelength; compatible
with gradient analysis.
Simultaneous multianalyte
analysis
The ability to detect
sensitivity, mass accuracy,
and resolution
Good capability of
separating complex samples
limited elution time means
relatively short separation
time at high efficiencies
high separation power
separates ionic and neutral
compounds
Only requires a few
nanoliters of sample
Can separate small
molecules

Disadvantage
•
•

•
•
•

Expensive
Not portable
Requires an experienced
technician

•

limited elution time limits
peak capacity of technique
generally limited to
compounds which are
reasonably soluble in the
mobile phase
low sensitivity in low
concentrations

•

•

•

HPLC, ELISA
[100]

•
•

Simple procedure
High specificity and
sensitivity Easy to perform
with simple procedure

Analytes must have
chromophoric activity.
The mobile phase must be
transparent to UV to have
acceptable sensitivity and
linearity

•

•
•

It required effort and time
and expensive to prepare
antibody
The used culture media is
expensive as well as it
requires sophisticated
techniques.
High possibility of false
positive/negative
Antibody instability
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Chapter 2: Materials and Methods
2.1 Materials
Standard metabolites and other chemical solvents for this project were obtained from
different sellers’ company. Vitamin A standard in the form of Retinol, 25Hydroxyvitamin D3 (6, 19, 19-d3), Albumin from human serum was purchased from
Green Oasis Medical Equipment Installation and maintenance (Gomet). Phosphate
buffered saline, and other solvents such as methanol, deionised water, hexane, ethyl
acetate, formic acid, ammonium format, LC-MS-grade water, and LC-MS-grade
methanol were purchased from Emirates Scientific and Technical Supplies L.L.C in
Abu Dhabi (ESTS). Ascentis Express F5 column (dimensions: 150 mm x 2.1 mm x
2.7 um) was purchased from LABCO LLC.
2.2 Methods
2.2.1 Preparation of standard solutions
The ethanol has been used to prepare the stock solution of Vitamin A (Retinol) and
25-Hydroxyvitamin D3 (6, 19, 19-d3) (Internal Standard) at a concentration of 1mg
/ml (1000 ug/ml). Amber vials have been used to store the stock solutions at -20°C to
avoid degradation. The diluting and mixing stock solutions in methanol solvent have
been used to prepare the working solutions of Vitamin A and Internal Standard by
using the methanol solvent to reach a desired concentration for the analysis. The
preparation of working solutions was protected from exposure to the light during the
laboratory process to minimise vitamin degradation.
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2.2.2 Collection of blood samples
Blood samples (1 mL) were attained from 277 Emirati individuals from obese Emirati
patients including 277 baseline, 277 follow-ups, while the study covered additional
175 healthy participants. The characteristics of the sample as follows: mixed-gender
with 73 males in the age group of (18–82 years) and 204 females in the age group of
(18–65 years). While in the health sample the number of males is 8 while the number
of females is 167. A centrifugation process to separate serum with a scale of 1500x
has been implemented for the collected blood samples, and the resulting serum was
extracted. Afterwards, a freezing process was completed by freeze the serum samples
individually in labelled plastic amber vials. The ethics approval has been granted and
approved by UAEU research ethics committee under ethics approval of Protocol
number (AAHEC-3-17-055) for recent Vitamin D study samples.
2.2.3 Extraction method
The human plasma samples were stored in the refrigerator at -80oC. Once the analysis
of these samples begins, they were thawed to room temperature. 500 µl of serum
samples were treated into Culture Tube, Borosilicate Glass, 16 x 100mm, 14mL.
Subsequently, A 20 µl of Internal Standard were added with a concentration of 1 µg/ml
to spike the samples. After that, Internal Standard and an aliquot of plasma sample
solution were vortexed for 1 minute. Then, 1.0 mL of hexane: ethyl acetate (9:1)
mixture has been added in the process to extract vitamin A and Internal Standard in
the plasma samples and later vortexed for a few seconds. After vortexing the samples,
they were centrifuged at 4000 rpm (round per minute) for 20 minutes at regular
conditions. After that, the resulting supernatant was separated using Pasteur pipettes
into a new set of a borosilicate culture tube glass. The remaining lower layer was
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further extracted twice by repeating the same steps mentioned above, starting from 1.0
mL of hexane: ethyl acetate (9:1) mixture. A further and additional extraction has been
conducted in which the resulted extracts were combined together into a new test tube;
then dried using room temperature under a flow of air in a sample concentrator. The
dried samples were then re-concentrated by adding 100 µl of LC-MS/MS grade
methanol. Finally, the samples were transferred into LC-MS/MS amber vials and
placed in an autosampler where the samples were kept at 4°C. A 5 ul in LC-MS/MS
instrument has been set under the injection volume of sample extract.
2.2.4 Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
The Chromatogram of vitamin A was achieved with the Nexera ultra-high-pressure
liquid chromatography (UHPLC) system (Shimadzu, Japan) on a reversed-phase
column Ascentis Express F5 column (dimensions: 2.7 µm particle size, L x I.D. 15cm
x 2.1 mm). The F5 column for physical filtration has been connected to the guard
column. The temperature for the column was kept at 30°C with the mobile phase flow
rate of 0.5 ml/min in the UHPLC system. There are two mobile phases that were
utilised in the system (Figure 5):
•

Mobile phase A is the LC-MS/MS grade water with 0.1% formic acid or 5 mM
ammonium format.

•

Mobile phase B is LC-MS/MS grade methanol with 0.1% formic acid or 5 mM
ammonium format.
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Mobile Phase Gradient
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20:00
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40%
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0%

0%

15:00

16:00

0%
0

11:00

Time (min)
mobile phase B

Mobile Phase A

Figure 5: Mobile phase gradient elution profile used for the LC-MS experiments
Mobile phase A and B are presented in the upper and lower line, respectively. The
amount of Mobile phase A presented in water with 5mM ammonium format, while the
amount of Mobile phase B presented in methanol with 5mM ammonium format. As
shown in the figure, the upper line begins at 80% of the composition and steadily
increases to 100% before decreasing to 80% at the time of 16:10. At the same time,
the lower line begins at 20% and steadily decreases down to 0% before increasing to
20% at the time of 16:10.
The mobile phase gradient was set as follows: The mobile phase B was set at 75% for
11 min, while mobile phase A was set at 25%. Afterwards, the mobile phase B was
increased to 100% from 11-15 min and retained the same percentage up until to 16
min whereas mobile phase A reduced to 0% for the duration of that period. Then, the
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percentage of mobile phase A increased to 25% while the percentage of mobile phase
B was reduced to 75% from 16:00 to 16:10 min and maintain the percentage of both
mobile phases consistent to 20:00 min, where the mobile phase gradient ends. The
mass spectrometry analysis was conducted on Shimadzu, model 8060, with a triple
quadrupole mass spectrometry system that is operated in positive electrospray
ionisation (ESI) mode (Figure 6).

Figure 6: LC-MS/MS - Shimadzu, model 8060 - UAEU laboratory
The Nebulising gas flow was set at 2 L/min while drying, and heating gas flow was 8
L/min at 300°C of interface temperature (Table 4). It has been shown that the increased
flow rate results in reduced signal intensities. This decrease in signal intensity could
be attributed to the loading of plasma with the gas which may change its nature through
various reactions eventually leading to interference with the signal intensity [15]. The
positive electrospray ionisation (ESI) mode has been used to function the mass
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spectrometer (MS); it was beneficial due to the achievement of enhancement of ion
signal intensity and reducing noise. The favour goes to the newly developed UFQarray ion guide technology that increases sensitivity. A new level of sensitivity is
presented in the used instrument of LCMS-8060, where data is controlled, functioned
and analysed using the Shimadzu’s Lab Solutions software.

Table 4: MS parameters for nebulising, drying, and heating gas flow, followed by
interface and heating block temperature
Ms Parameters

Ms Conditions

Nebulising gas flow

2 L/min

Drying gas flow

8 L/min

Heating gas flow

8 L/min

Interface temp.

300°C

Heating block temp.

400°C

2.2.5 Validation method
The validation has been implemented based on the requirements and recommendations
of the US Food and Drug Administration (FDA) guidelines for method validation.
Accordingly, the validation has been conducted for the purpose of stability, recovery,
accuracy, specificity, precision, and linearity [101]. There are four control limits have
been stated (QCs) in four different concentrations as following: higher quality control
limit (QCH) with a concentration of 800 ng/mL, (QCM) medium quality control limit
with 400 ng/mL and (QCL) lower quality control limit with a concentration of 200
ng/mL, and finally, (LLOQ) with a concentration of 100 ng/mL. The stated quality
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controls have been analysed to calculate the linearity, intra-day and inter-day
precision, and accuracy of the vitamin A assays. The analysis, in each validation,
includes the six controls at each concentration level (QCH, QCM, QCL, and LLOQ)
together with a calibration curve. A blank serum has been used to prepare the
calibration curves and all quality control samples. A published recipe has been used to
make the blank serum, in which the human serum albumin is mixed with phosphatebuffered saline at a concentration of 50 g/L [102]. The recovery was calculated in the
recovery experiment, where the six quality control samples at four different
concentrations (800 ng/mL, 400 ng/mL, 200 ng/mL, and 100 ng/mL) were spiked with
methanol. A repeated experiment with four similar concentrations was used, with
blank serum samples spiked with quality controls, and the recovery was calculated and
compared using the peak area results (or area under the normal curve). Then a stability
experiment was measured and checked by examining six controls at each
concentration level (800 ng/mL, 400 ng/mL, 200 ng/mL, and 100 ng/mL), executing
three freeze/thaw cycles of the spiked quality controls at 0 h, 24 h, 48 h, and 72h.
The representative chromatogram of vitamin A is spiked and taken out using the
retention time and multiple reaction monitoring (MRMs) for the accurate
quantification of small molecules in serum. As mentioned above in the validation
approach followed in the study there are six QC samples were analysed at four
different levels of concentration (QCH = 800 ng/mL, QCM = 400 ng/mL, QCL = 200
ng/mL, LLOQ = 100 ng/mL). These standards, as shown in Table 5, are used to gauge
the average, intra/inter-day accuracy, specificity, recovery, linearity, stability,
intra/inter-day precision. Each value in those parameters was calculated based on
approved equations. The equation of [(mean value/nominal value)×100] has been used
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to calculate the percentage of intra/inter-day accuracy of the assay of the QC values.
While the equation of [(standard deviation/mean)×100] has been used to calculate the
percentage of intra/inter-day precision (% CV) values from QC values. The equation
of [(mean unextracted QC values/mean extracted QC values)×100] has been used to
calculate the percentage of absolute recoveries. The lower limit of detection (LOD),
which is LOD is the lowest analyte concentration can be reliably detected from the
limit of blank and at which detection is feasible. It is calculated based on the Signalto-Noise approach by correlating the signal-noise ratio to the analytes lowest
concentration, decided by reducing the analyte concentrations until a response
equivalent to three times “3x” the detected background level. The generally acceptable
detection limit for the single/noise ratio equals 3 “three”.
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Chapter 3: Results and Discussion
3.1 Validity results
The favourable linear range for all the analytes was 7.8125–1000 ng/mL, with a very
good regression value (R2 = 0.999). Finally, as appearing in Figure 7, the specificity
of the validation was calculated by coating the peaks to check for any interfering/coeluting peaks at the particular retention times of the analytes. The specificity
calculation based on the outcomes achieved by extracting and analysing many blank
serum QC samples.
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Figure 7: A spiked and extracted representative chromatogram of vitamin A along
with the retention time and multiple reaction monitoring (MRMs) with internal
standard 25-Hydroxyvitamin D3 (6, 19, 19-d3)
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Shimadzu 8060, which represents a novel instrument that has been found to offer a
high degree of sensitivity, was selected to ensure accurate detection of analyte ions
over a 20-min run. The MRM transitions were selected from the [M+H]+ protonated
molecules in the electrospray ionisation source. The MRM mode was used to monitor
the most sensitive precursor ions, which were predominantly seen after the retinol
Vitamin molecule lost a water molecule and the most sensitive product ions. A direct
infusion of standard compound mixtures and individual solutions was used to optimise
the MRM parameters of each analyte. The selected MRM transitions were confirmed
using the Shimadzu 8060 optimiser.
•

Calibration Curve

A blank serum has been used to prepare the calibration curve and all quality control
samples. The human serum albumin is mixed with phosphate buffered saline at
concentration of (50 g/ml). The favorable linear range for all the analytes was 7.8125–

Area

1000 ng/mL with a very good regression value (R2 = 0.999) (Figure 8).

Concentration (ng/ml)
Figure 8: Calibration curve to determine the quality of the samples
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Table 5: The values of method validation parameters for each quality control level
N Analytes

Conc.
(ng/mL)

Intra-day
Precision
%
(% CV) Accuracy

1

Vitamin
A

Linear
%
LOD
range
Recovery (ng/m)
(ng/mL)

Inter-day

SD

Precision
%
(% CV) Accuracy

SD

QCH
800

0.07

100.09

0.52

0.09

100.09

0.69

99

0.488

QCM
400

0.09

100.09

0.38

0.06

100.09

0.23

96

0.488

QCL
200

0.17

100.28

0.35

0.06

100.24

0.12

94

0.488

LLOQ
100

0.29

100.73

0.3

0.27

100.81

0.27

7.811000

0.488

Table 5 shows the names of the analytes and concentrations at the four quality control
levels (QCH, QCM, QCL, LLOQ), the criteria presented: the intra-day and inter-day
precision and accuracy results with the standard deviation, per cent recovery, the limit
of detection (LOD) values, and linear range in ng/mL. Table 5 presents an overview
of the selected MRM transitions together with their respective parameters. The
validation method parameters are in acceptable range for the three QC levels. For
example, the accuracy and precision indicators signify that the goodness of the method
used to analyse vitamin A metabolites for intra and inter-day, with accuracy
significantly close to 100% and precision ranged from 0.07 to 0.29 for the four
concentration. Increasingly, as presented in Table 5, the calculated recovery
percentage shows that the extraction method is efficient in extracting vitamin A
metabolites from serum samples. The literature has shown different values in terms
of the LOD and LOQ values. For example, Plozza et al. reported the LOQ for 0.1
μg/100 mL for all trans-retinol and α-tocopherol and 1 μg/100 mL for β-carotene [83].
Furthermore, Midttun and Uelan reported the LOD 0.1 μM for all-trans retinol [97].
In another study for Santos et al., the LOD and LOQ were reported 0.07–170 ng/mL
and 0.2–520 ng/mL respectively [18]. Moreover, Gentili et al. have reported for LOD
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0.9–15.6 μg/L and 2.7–46.8 μg/L for LOQ [85]. Table 5 shows the values of LOD and
LOQ for vitamin A by LC-MS/MS 8060, which explain that the method is extremely
sensitive. The table also presents the intra and inter-day coefficient of variation and
accuracy marks among four quality control level. The recovery percentage were
calculated by comparing areas under the normal curve in the chromatogram for the
extracted and unextracted quality control samples. The LOD was concluded from the
lowest concentration of vitamin A metabolite that can be detected by the instrument.
Many blank serum QC samples have been used to calculate the specificity of the
validation. This calculation has been done by the extracting and analysing the blank
serum QC sample. The peaks were overlaid to check for any interfering/co-eluting
peaks at the respective retention times of the analytes, as shown in the following
Figure 9.

Intensity
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Retention Time (min)
Figure 9: An overlay of six chromatographic peaks showing the specificity of the
assay. No interfering co-eluting peaks were found for vitamin A.
Checking the internal standard response of each sample within a batch is also a useful
way of picking up problems with individual samples. The precursor and product ions
of vitamin A and internal standard with their collision energies are illustrated in Table
6. The table shows optimum MS/MS parameters: precursor ion (m/z) 269.25, product
ion 93.05 at collision energy -22 V, 91.10 m/z at -43.0 V and 95.15 at a collision energy
of -15.0 V. The table also presents the chemical structure of the retinol with a retention
time of 6.720 minutes and mass of 286.45 g/mol.
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Table 6: Names, structure, mass, precursor and product ions along with collision
energies
Name

Structure

Retinol (Vitamin A)

Retention Mass
time
(g/mol)

6.720

286.45

Precursor
ion (m/z)

269.25

Product
ion (m/z)

Collision
energy
(eV)

93.05

-22.0

91.10

-43.0

95.15

-15.0

368.25

-15

257.2

-183

95.2

-35

C20H30O

25-Hydroxyvitamin
D3 (6, 19, 19-d3)

6.482

403.66

386.35

C27D3H41O2

As shown in Figure 10 Stability tests were operated over 24 h, 48 h, and 72 h, where
the outcomes were compared with time zero. The percentage of change from time = 0
is presented in the figure for the four used concentration levels of 800 ng/mL, 400
ng/mL, 200 ng/mL, and 100 ng/mL, where they are used for gauging the stability for
Vitamin A. As appearing in the graph, Vitamin A shows a percentage of change up to
0.08% in 24 h of the freeze/thaw cycle, while the % change was within 0.16% for 48
and 0.50% for 72 h in a concentration level of 400 ng/mL. While in the concentration
level of 800 ng/mL the % change has fluctuated between -0.05% in 72 h and 0.02 in
48 h and -0.02 in 24 h. The % of the change in the concentration level of 100 ng/mL
has shown -0.15% in 24 h, -0.13% in 48 h, and 2.96% in 72 h. It appears from the
figure that the Vitamin A is stable when exposed to continuous freezing and thawing
cycles. The LC–MS/MS method has proven its reliability, accuracy, reproducibility,
specificity and robust.
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Figure 10: The stability of vitamin A in serum after three freeze/thaw cycles
The blue, orange and grey bars represent the % change in concentration of a particular
vitamin A at 24 h, 48 h, and 72 h’ intervals, respectively, with the use of quality
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controls at four different concentration levels, LLOQ-100 ng/ml, QCL-200 NG/mL,
QCM-400 ng/ml, and QCH-800 ng/ml. The percentage of change in the stability of
vitamin A ranges between 0 and 3%. The error bars in the graph represent the standard
errors of the mean.
3.2 Results of obese Emirati samples

Female
900

Concentration (ng/ml)

800

702

700
600
500

440

372

400

300
200
100
0
Baseline

Follow-up

Healthy

Vitamin A

Figure 11: A comparative account of vitamin A concentration in Emirati female
blood samples
From left to right, baseline concentrations of vitamin A, and follow-up, and healthy
volunteers are shown by blue and orange and green bars, respectively. Vitamin A
deficiency is a clinical condition (dryness in the eyes, poor growth of bones, and some
specific skin conditions, etc.). In the laboratory, vitamin A deficiency is defined as a
level below 20 micrograms/dL (.7 micromole/L). The upper limit of normal vitamin
A is 60 micrograms/dL.
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Table 7: Vitamin A indicators
Condition

ng/ml

Deficient

< 200

Optimal

≥ 200 to ≤ 600

High

≥ 600 to < 1000

Hypervitaminotic

≥ 1000

Table 7 [103] shows the vitamin A range guideline from the literature. This range has
been followed in the result and discussion part by comparing the achieved findings
with these indicators.

Male

1400

1054

Concentration (ng/ml)

1200

1000
800
600

540

438

400
200
0

Baseline

Follow-up

Healthy

Vitamin A

Figure 12: The comparative accounts of vitamin A concentrations in Emirati male
blood samples. From left to right, the concentrations of vitamin A in baseline and
follow-up, and healthy volunteers are shown by blue and orange and green bars,
respectively.
Figures 11 and 12 show the analysis of blood samples from a sample of the Emirati
population in the UAE for both female and male patients, respectively using the
developed and validated LC–MS/MS method. The proportion of female sample to
male sample is (2.8:1) in baseline and follow sample, as also the female patients
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usually return for follow-up sessions compared to the male patients. The level of
vitamin A deficiency appears in the baseline volunteers in the female sample which
presented in the blue bar in the female results, which is higher than the lower
acceptable value of (600 ng/mL >372 ng/ mL > 200 ng/ mL). This result has increased
upon supplementation in the follow-up samples to reach 440 ng/mL. On one hand, the
male results were within the acceptable upper and lower limits (600 ng/mL> 438
ng/mL > 200 ng/mL, 200 ng/mL< 540 ng/mL < 600 ng/mL). The healthy sample has
achieved an extremely high number for male to achieve 1045 ng/mL, while in female
this reached 702 ng/mL. The healthy sample size is lower than the baseline and followup sample with 175 participants whom age rages between (18:65 years). The results
clearly show that the concentrations of vitamin A for both females and males increased
after supplementation (372 ng/mL to 440 ng/mL for female sample, and 438 ng/mL to
540 ng/mL for male sample). The result shows a sufficient level of vitamin A in the
participants.

Table 8: A comparative account of the vitamin A in the baseline, and follow-up
samples. The average concentration of vitamin A is given in the last column (in ng/ml)
along with the standard deviation (SD). N signifies the number of samples analysed in
this study from baseline and follow-up.
Vitamin

Vitamin A

Sample Type

N

Mean ± SD

Baseline

277

389±215

Follow Up

277

466 ± 232

Healthy

175

1054±344

As appears in Table 8 for vitamin A with a total sample of 277, including the male and
female, the calculated mean for the baseline is 389 plus and minus the standard error.
This increased in the supplementations to achieve 466 plus and minus the standard
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error. Surprisingly, the healthy sample has shown a dramatic increase to reach 1054
plus and minus the standard error.

Samples
900
800
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Concentration (ng/ml)
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400

Follow-up

300

Healthy

200
100
0
Baseline

Follow-up
Vitamin A

Healthy

Figure 13: A comparative account for vitamin A concentration at baseline, follow-up
and healthy samples. The error bars in the graph represent the standard errors of the
mean.
Figure 13 shows the combined results for both female and male participants where the
baseline samples for obese Emirati patients were above the optimal levels of vitamin
A (389 ng/mL > 200 ng/mL), and, similarly, the follow-up sample results showed
higher and acceptable results for vitamin A (200 ng/mL > 466 ng/mL > 600 ng/mL).
While the healthy sample has achieved 7018 ng/mL. The result from the current
analysis shows that vitamin A is present in the blood with acceptable limits according
to the approved guidelines (Figure 7). Additionally, the perceived results also suggest
that the current supplementation strategy for vitamin A in the UAE for the Emirati
population may is acceptable and favourable.

47

Chapter 4: Conclusions
In summary, the current research intended to develop a LC-MS/MS-based assay for
quantifying vitamin A in human plasma in healthy and diseased Emirati population.
The reached findings show the suitability and robust LC-MS based assay for the
simultaneous quantification of vitamers in human plasma where the stability of
vitamin A ranges between 0 and 3%, and optimum MS/MS parameters: precursor ion
(m/z) 269.25, product ion 93.05 at collision energy -22 V, 91.10 m/z at -43.0 V and
95.15 at a collision energy of -15.0 V. The research methodology has followed the
preparation procedures of standard solutions, and collection of blood samples and
ethical approval number. The MRM-based LC-MS/MS method has been used to
extract and analyse the vitamin A from the human plasma. The method has been
applied on a sample of 277 Emirati obese patients for the baseline and the patients
have been followed-up, while new 175 healthy control volunteers participated. The
characteristics of the sample as follows: mixed-gender with 73 males in the age group
of (18–82 years) and 204 females in the age group of (18–65 years). The level of
vitamin A appears in the baseline volunteers in the female sample which is higher than
the 200 ng/ mL and less than the 600 ng/mL. This perceived result has increased upon
supplementation in the follow-up samples to reach 440 ng/mL. While the male results
are within the acceptable limits upper and lower limits for the (600 ng/mL> 438 ng/mL
> 200 ng/mL, 200 ng/mL< 540 ng/mL < 600 ng/mL). The healthy sample showed 718
ng/mL combining the female and male. The results clearly show that the
concentrations of vitamin A for both females and males increased after
supplementation (372 ng/mL to 440 ng/mL for female sample, and 438 ng/mL to 540
ng/mL for male sample), this increase has made the values become within the optimal
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range as shown in the Table 6. The result shows a sufficient level of vitamin A in the
participants.
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